IFNA1 and cancer: For instance, interleukin-2 (IL-2) and interferon-alpha (IFN-a), which are produced by T-lymphocytes and leukocytes, respectively, have been used clinically in the recombinant form for cancer management, and both have been associated with cardiotoxicity22.